Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition

H Foo1, E Mak2, T T Yong1

  • 1Department of Neurology, National Neuroscience Institute, Singapore.

Abstract

Insights

Parkinson's disease patients with cognitive decline show specific patterns of brain atrophy, particularly in the thalamus and caudate nucleus. This subcortical atrophy is linked to memory and executive function deficits, potentially serving as a biomarker for future dementia.

Area of Science:

  • Neuroscience
  • Neurology
  • Radiology

Background:

  • Mild cognitive impairment (MCI) is linked to brain atrophy.
  • The relationship between atrophy patterns and the progression from no cognitive impairment (NCI) to Parkinson's disease MCI (PD-MCI) requires further investigation.

Purpose of the Study:

  • To investigate the pattern and progression of subcortical atrophy in patients with mild Parkinson's disease (PD).
  • To determine the impact of this atrophy on cognitive function in PD patients.

Main Methods:

  • Structural MRI scans and longitudinal clinical/neuropsychological assessments were used for 65 mild PD patients.
  • Patients were classified as PD-NCI (n=54) or PD-MCI (n=11), and further categorized into PD-stable (n=42) or PD-converters (n=12) over 18 months.
  • FreeSurfer software analyzed cortical thickness and subcortical volumes at baseline and follow-up.

Main Results:

  • PD-MCI patients exhibited baseline thalamus atrophy and progressive atrophy in the thalamus, caudate, and hippocampal subfields, correlating with memory and executive dysfunction.
  • PD-converters showed greater baseline accumbens atrophy and progressive atrophy in the thalamus, caudate, and accumbens, accompanied by cognitive deficits.

Conclusions:

  • Cognitive impairment progression in non-demented PD is associated with distinct subcortical atrophy patterns.
  • Subcortical structures may serve as potential biomarkers for predicting Parkinson's disease dementia.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
636
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.0K